Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Sorafenib and Radiation Therapy in Patients With Hepatocellular Carcinoma

NCT00892658 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00892658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00892658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Sorafenib and Radiation Therapy in Patients With Hepatocellular Carcinoma
Lead sponsor
University Health Network, Toronto
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2009
Completion date
December 16, 2020
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma